Organic Active Ingredients TRIZ Cases

Substituted imidazole 4-carboxamides act as selective ligands for the human cholecystokinin-1 receptor.

A retainer holds antimicrobial solution against tissue while light terminations deliver specific wavelengths to activate the chemical.

An amino alcohol derivative targets the S1P1 receptor to down-regulate lymphocyte egress from lymph nodes.

Topical strontium complexes combine with cysteine antioxidants to amplify anti-irritant effects on sensory nerves.

Crosslinked sulfated polysaccharide films resolve mucoadhesion-toxicity trade-offs while improving bioavailability and pathogen protection.

Crystallizing amorphous CDB-4124 into stable Form A resolves purity versus process complexity by replacing chromatography with simple filtration.

Compounds inhibit EGFR dimerization and induce protein degradation to overcome osimertinib resistance in lung adenocarcinoma.

Interfering compounds target the NiRAN domain of nsp12 to prevent UMPylation and stop viral RNA synthesis across mutant strains.

Oral small molecule replaces complex intravenous infusion by selectively increasing plasma levels of correctly folded Z A1AT.

Optimized granule bulk density resolves the contradiction between reduced volume and rapid disintegration for amino acid preparations.

L2/L1 microemulsions partition lipophilic delmopinol into lipid droplets, extending retention time on oral surfaces against saliva flow.

Methods detect HPV-specific CD8+ T-cell clonal expansions to diagnose severe erosive oral lichen planus, addressing the lack of accurate diagnostic tools.

Controlled oxidation removes pyrogens from seaweed extracts without damaging biological activity, enabling safe parenteral use.

Cladribine selectively depletes pathogenic immune cells, providing rapid symptom relief and sustained remission without frequent retreatment.

Novel tetracyclic pyridone compounds inhibit hepatitis B virus protein activity and interfere with the viral life cycle.

Parabacteroides strains inhibit oncogenic ERK signalling to treat cancers with BRAF mutations.

A molecular construct links an anti-CD38 antibody to lenalidomide molecules for targeted delivery.

Pyridazine quinoline analogs activate the SMN promoter and stabilize protein to address insufficient levels in spinal muscular atrophy.

Triazolopyridine compounds act as corticotropin-releasing factor antagonists to inhibit tau protein phosphorylation.

Amino-piperidine derivatives enhance CETP inhibition effectiveness, resolving insufficient activity levels while modulating lipoprotein profiles.

Medium chain triglyceride emulsion eliminates ethanol contamination risks and simplifies synthesis while maintaining stability.

Buffer agents stabilize dimeric naphthalimide compounds within a pH range of 5 to 7, preventing degradation and minimizing impurity formation.

Amide and ester modifications boost polynucleotide delivery while maintaining nanoparticle stability.

Lyophilization with cryoprotectants prevents liposome aggregation and hydrolysis, maintaining immunostimulatory activity without toxicity.

Heating a potassium citrate and carnauba wax mixture below the wax liquefaction point forms granules for direct tablet processing.

Polymannan extract compositions increase natural killer cell levels by 75-80% to treat leukemias, lymphomas, prostate cancer, breast cancer, and colon cancer.

Segmenting the formulation into distinct layers allows polyethylene oxide to prevent sticking while maintaining desired release profiles.

A delivery molecule combines a cargo, a GAG binding element, and a protein transduction domain to facilitate cellular uptake.

Substituted heterocycle fused gamma-carbolines provide selective 5-HT2A receptor antagonism to reduce dopamine D2 side effects in CNS disorder treatments.

Developing specific hydrates and solvates resolves stability issues while maintaining pharmaceutical manufacturability.

Beta-alanine supplementation raises brain carnosine levels and maintains BDNF expression to reduce anxiety in post-traumatic stress disorder.

Pyrrolidine flavone derivatives treat HPV-associated cancers by upregulating p53 and downregulating E6/E7 oncoproteins to inhibit tumor growth.

RNA interference silences HAO1 to lower urinary oxalate and slow renal damage in Primary Hyperoxaluria Type 1 patients.

Pyrazole triazole derivatives resolve low potency and specificity issues by targeting STIM1 and Orai1 proteins to regulate calcium entry.

Immunotherapeutic agents reduce inflammatory cytokines to improve upper airway patency without cumbersome mechanical devices.

Novel crystalline and amorphous solid forms of a GLP-1 agonist salt enable oral pharmaceutical compositions.

N-cyclopropyl-N-piperidinyl-amide derivatives activate the cAMP pathway in beta cells, improving glycemic control without hypoglycemia risk.

Oral flavonoid PKCγ inhibitors reduce manic symptoms by targeting specific molecular pathways, avoiding traditional drug side effects.

Phenolic compounds inhibit elastase-mediated elastin degradation to prevent aneurysm progression without invasive surgical interventions.

Conjugating semaxanib to a polymer improves pharmacokinetic profiles and therapeutic efficacy beyond standalone limitations.

Dextro-methylphenidate establishes a positive feedback mechanism in the brain to enhance language learning abilities in children.

Double-stranded RNA interference oligonucleotides reduce ketohexokinase expression in the liver to treat non-alcoholic steatohepatitis.

Carbodiimide activation replaces unstable phosphodiester linkages, enabling efficient preparation of stable peptide-oligonucleotide conjugates.

Bispecific antibodies deplete dysfunctional CD38+PD-1+ T cells, reversing anti-PD1 therapy resistance and reducing tumor burden.

Modified desilylation and purification steps resolve the trade-off between high productivity and manufacturing precision for CL2A-SN-38 conjugates.